CARTITUDE-4 Study: Cilta-cel Benefits High-Risk Myeloma & EMD SubgroupsBySurbhi Sidana, MDJune 26th 2025Surbhi Sidana, MD, discusses updates from the CARTITUDE-4 study assessing the CAR T therapy cilta-cel in patients with multiple myeloma.